Implementing Strategic Restructuring to Eliminate Commercial Organization and Rationalize Operations Across All FunctionsPrioritizing Strong ...

scPharmaceuticals Inc. (NASDAQ: SCPH) Q3 2024 Earnings Call Transcript November 13, 2024 ...

Spirulina, an algae, is thought to be one of the oldest life forms on earth, with research suggesting it was first used by ...

One particular food item that's packed full of protein has been linked to lowering cholesterol and reducing your risk of ...

"Learning and memory are generally associated with brains and brain cells alone, but our study shows that other cells in the body can learn and form memories, too," explains New York University's ...

Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the American Journal of Kidney Disease has ...

Chronic kidney disease can be classified by the extent of your kidney damage. These classifications range from mild, mild to moderate, moderate to severe, severe, and then to most severe kidney ...

The Advisory Committee voted 11 to 3 that the benefits of ZYNQUISTA do not outweigh the risks in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD), as defined in the voting question .

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencel; ...

For adults with stage 3 chronic kidney disease, predicted 10-year CVD risk was elevated at age 60 for women and 55 for men. This is 8 years younger than expected for men and women without CKM ...

WALTHAM, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...